The role of plasminogen activator inhibitor-1 as inhibitor of platelet and megakaryoblastic cell adhesion

British Journal of Haematology

Volumn 104, Issue 4, 1999, Pages 901-908

  Wohn, Karl Dieter ^a   Schmidt, Thomas ^a   Kanse, Sandip M ^a   Yutzy, Barbara ^a   Germer, Matthias ^a   Morgenstern, Eberhard ^b   Preissner, Klaus T ^a,c  

^a KERCKHOFF HEART CENTER   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Adhesion; Integrin; Megakaryoblast; PAI 1; Platelet; Vitronectin

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; VITRONECTIN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; COMPLEX FORMATION; CONCENTRATION RESPONSE; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HUMAN; HUMAN CELL; MEGAKARYOBLAST; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING;

EID: 0033003253     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01242.x     Document Type: Article

References (41)

1. Andreasen, P.A., Kjoller, L., Christensen, L. & Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis. International Journal of Cancer, 72, 1-22.
2. Asch, E. & Podack, E.R. (1990) Vitronectin binds to activated human platelets and plays a role in platelet aggregation. Journal of Clinical Investigation, 85, 1372-1378.
3. Carmeliet, P. & Collen, D. (1997) Molecular genetics of the librinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis. Current Opinion in Lipidology, 8, 118-125.
4. Collins, W.E., Mosher, D.F., Tomasini, B.R. & Cooper, S.L. (1987) A preliminary comparison of the thrombogenic activity of vitronectin and other RGD-containing proteins when bound to surfaces. Annals of the New York Academy of Sciences, 516, 291-299.
5. Connolly, D.T., Knight, M.B., Harakas, N.K., Witwer, A.J. & Feder, J. (1986) Determination of the number of endothelial cells in culture using acid phosphatase assay. Analytical Biochemistry, 152, 136-140.
6. de Boer, H.C., Preissner, K.T., Bouma, B.N. & de Groot, P.G. (1995) Internalization of vitronectin-thrombin-antithrombin complex by endothelial cells leads to deposition of the complex into the subendothelial matrix. Journal of Biological Chemistry, 270, 30733-30740.
7. Declerck, P.J., De Mol, M., Alessi, M.-C, Baudner, S., Paques, E.-P., Preissner, K.T., Müller-Berghaus, G. & Collen, D. (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: identification as a multimeric form of S protein (vitronectin). Journal of Biological Chemistry, 263, 15454-15461.
8. de Groot, P.G. & Sixma, J.J. (1996) Platelet adhesion. Vascular Control of Haemostasis (ed. by V. W. M. van Hinsbergh), p. 147. Harwood Academic Publishers, Amsterdam.
9. Deng, G., Royle, G., Seiffert, D. & Loskutoff, D.J. (1995) The PAI-1 vitronectin interaction: two cats in a bag. Thrombosis and Haemostasis, 74, 66-70.
10. DiCorleto, P.E. & de la Motte, C.A. (1989) Thrombin causes increased monocytic-cell adhesion to endothelial cells through a protein kinase C-dependent pathway. Biochemical Journal, 264, 71-77.
11. Fugman, D.A., Witte, D.P., Jones, C.L., Aronow, B.J. & Lieberman, M.A. (1990) In vitro establishment and characterization of a human megakaryoblastic cell line. Blood, 75, 1252-1263.
12. Gailit, J. & Clark, R.A.F. (1994) Wound repair in the context of extracellular matrix. Current Opinion in Cell Biology, 6, 717-725.
13. Hess, S., Kanse, S.M., Kost, C. & Preissner, K.T. (1995) The versatility of adhesion receptor ligands in haemostasis: morpho-reglatory functions of vitronectin. Thrombosis and Haemostasis, 74, 258-265.
14. Hill, S.A., Shaughnessy, S.G., Joshua, P., Ribau, J., Austin, R.C. & Podor, T.J. (1996) Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line. Blood, 87, 5061-5073.
15. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
16. Izumi, M., Yamada, K.M. & Hayashi, M. (1989) Vitronectin exists in two structurally and functionally distinct forms in human plasma. Biochimica et Biophysica Acta, 990, 101-108.
17. Kanse, S.M., Kost, C., Wilhelm, O.G., Andreasen, P.A. & Preissner, K.T. (1996) The urokinase receptor is a major vitronectin binding protein on endothelial cells. Experimental Cell Research, 224, 344-353.
18. Keijer, J., Linders, M., Wegman, J.J., Ehrlich, H.J., Mertens, K. & Pannekoek, H. (1991) On the target specificity of plasminogen-activator inhibitor-1: the role of heparin, vitronectin, and the reactive site. Blood, 78, 1254-1261.
19. Kjoller, L., Kanse, S.M., Kirkegaard, T., Rodenburg, K.W., Ronne, E., Goodman, S.L., Preissner, K.T., Ossowski, L. & Andreasen, P.A. (1997) Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Experimental Cell Research, 232, 420-429.
20. Kost, C., Stüber, W., Ehrlich, H., Pannekoek, H. & Preissner, K.T. (1992) Mapping of binding sites for heparin, plasminogen activator inhibitor-1 and plasminogen to vitronectin's heparin binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. Journal of Biological Chemistry, 267, 12098-12105.
21. Landegren, U. (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: applications to detection of lymphokines and cell surface antigens. Journal of Immunological Methods, 67, 379-388.
22. Mimuro, J. & Loskutoff, D.J. (1989) Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells. Journal of Biological Chemistry, 264, 5058-5063.
23. Mohri, H. & Ohkubo, T. (1991) How vitronectin binds to activated glycoprotein IIb-IIIb complex and its function in platelet aggregation. American Journal of Clinical Pathology, 96, 605-609.
24. Morgenstern, E. & Preissner, K.T. (1993) The distribution of vitronectin in resting and thrombin stimulated platelets: an ultra-immunocytochemical study. Biology of Vitronectins and their Receptors (ed. by K. T. Preissner, S. Rosenblatt, J. Wegerhoff and D. F. Mosher). pp. 99-102. Elsevier Science, Cambridge, Mass.
25. Munch, M., Heegaard, C.W. & Andreasen, P.A. (1993) Interconversion between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor. Biochimica et Biophysica Acta, 1202, 29-37.
26. Niculescu, F., Rus, H.G. & Vlaicu, R. (1987) Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis. Atherosclerosis, 65, 1-11.
27. Ogura, M., Morishima, Y., Okumura, M., Hotta, T., Takamoto, S., Ohno, R., Hirabayashi, N., Nagura, H. & Saito, H. (1988) Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters. Blood, 72, 49-60.
28. Panelti, T.S. & McKeown-Longo, P.J. (1993) Receptor-mediated endocytosis of vitronectin is regulated by its conformational state. Journal of Biological Chemistry, 268, 11988-11993.
29. Preissner, K.T. (1991) Structure and biological role of vitronectin. Annual Review of Cell Biology, 7, 275-310.
30. Preissner, K.T., Grulich-Henn, J., Ehrlich, H.J., Declerck, P., Justus, C., Collen, D., Pannekoek, H. & Müller-Berghaus, G. (1990) Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. Journal of Biological Chemistry, 265, 18490-18498.
31. Preissner, K.T., Holzhüter, S., Justus, C. & Müller-Berghaus, G. (1989) Identification and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood, 74, 1989-1996.
32. Preissner, K.T. & Pötzsch, B. (1995) Vessel wall-dependent metabolic pathways of the adhesive proteins, von Willebrand factor and vitronectin. Histology and Histopathology, 10, 239-251.
33. Preissner, K.T. Wassmuth, R. & Müller-Berghaus, G. (1985) Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochemical Journal, 231, 349-355.
34. Seiffert, D. & Schleef, R.R. (1996) Two functionally distinct pools of vitronectin (VN) in the blood circulation: identification of a heparin-binding competent population of VN within platelet α-granules. Blood, 88, 552-560.
35. Stefansson, S. & Lawrence, D.A. (1996) The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin. Nature, 383, 441-443.
36. Stockmann, A., Hess, S., Declerck, P., Timpl, R. & Preissner, K.T. (1993) Multimeric vitronectin: identification and characterization of conformation-dependent self-association of the adhesive protein. Journal of Biological Chemistry, 268, 22874-22882.
37. Thiagarajan, P. & Kelly, K.L. (1988) Exposure of binding sites for vitronectin on platelets following stimulation. Journal of Biological Chemistry, 263, 3035-3038.
38. Tomasini, B.R. & Mosher, D.F. (1990) Vitronectin. Progress in Hemastasis and Thrombosis, 10, 269-305.
39. Watkins, S.C.R. & Slayter, H.S. (1990) Immunoelectron-microscopic studies of human platelet thrombospondin, VN, Willebrand factor, and fibrinogen redistribution during clot formation. Histochemical Journal, 22, 507-513.
40. Wei, Y., Waltz, D.A., Rao, N., Drummond, R.J., Rosenberg, S. & Chapman, H.A. (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. Journal of Biological Chemistry, 269, 32380-32388.
41. Wohn, K.D., Kanse, S.M., Deutsch, V., Schmidt, T., Eldor, A. & Preissner, K.T. (1997) The urokinase receptor (CD87) is expressed in cells of the megakaryoblastic lineage. Thrombosis and Haemostasis, 77, 540-546.